TickerFacts.

Roivant Sciences Ltd. (ROIV): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.54
Year ended 2026-03-31
$5.232022-03-31: -$1.262023-03-31: -$1.422024-03-31: $5.232025-03-31: -$0.242026-03-31: -$0.54-$0.54
2022-03-31 EPS (Diluted) (USD per share) 2026-03-31
Period endedEPS (Diluted)Change YoYSource filing
2026-03-31-$0.54n/m2026-05-20, From 2025-04-01
2025-03-31-$0.24n/m2026-05-20, From 2024-04-01
2024-03-31$5.23n/m2026-05-20, From 2023-04-01
2023-03-31-$1.42n/m2025-05-29, From 2022-04-01
2022-03-31-$1.26n/a2023-06-28, From 2021-04-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Roivant Sciences Ltd. (ROIV)2026-03-31-$0.54n/m
Coya Therapeutics, Inc. (COYA)2025-12-31-$1.27n/m
Aclaris Therapeutics, Inc. (ACRS)2025-12-31-$0.53n/m
Bolt Biotherapeutics, Inc. (BOLT)2025-12-31-$17.85n/m
Adagene Inc. (ADAG)2025-12-31-$0.30n/m
BioAge Labs, Inc. (BIOA)2025-12-31-$2.24n/m
Xenon Pharmaceuticals Inc. (XENE)2025-12-31-$4.36n/m
International Stem Cell Corp (ISCO)2025-12-31-$0.05n/m
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31-$0.33n/m

Compare ROIV, COYA, ACRS, BOLT side by side · Screen every company in Pharmaceutical Preparations ↗